1. Monday, 23 July, 10:15-12:15 Hall 11B, RAI Amsterdam
Accelerating the development and uptake of the most needed drug formulations for children
Monday, 23 July, 10:15-12:15
Hall 11B, RAI Amsterdam

2. Disclosure Relations that could be relevant for the meeting
Company names
Sponsorship or refund funds
Support for work at the IAS includes or has incldued funding to the Industry Liaison Forum (ILF) from Abbott, AbbVie, Alere, Beckman Coulter, Cepheid, Cipla, Coral Healthcare, Female Health Company, Gilead Sciences, Janssen, Lupin, MSD, Omega Diagnostics, Roche Molecular Systems, Sysmex Corporation, ViiV Healthcare.
One representative from each of these companies is appointed to the multi-stakeholder ILF Advisory Group.
More information at
Payment or other financial remuneration
None
Shareholder rights
Other relations
Reference:

3. Accelerating the development and uptake of the most needed drug formulations for children
Monday, 23 July, 10:15-12:15